Align Technology (ALGN) is a publicly traded Healthcare sector company. As of July 24, 2026, ALGN trades at $168.10 with a market cap of $12.35B and a P/E ratio of 28.09. ALGN moved -2.39% today. Year to date, ALGN is +7.74%; over the trailing twelve months it is -17.58%. Its 52-week range spans $122.00 to $246.19. Analyst consensus is buy with an average price target of $208.08. Rallies surfaces ALGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ALGN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $168.10 |
| Market Cap | $12.35B |
| P/E Ratio | 28.09 |
| EPS | $5.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $246.19 |
| 52-Week Low | $122.00 |
| Volume | 653.70K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.10B |
| Net Income | $429.89M |
| Gross Margin | 67.57% |
13 analysts cover ALGN: 0 strong buy, 9 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $208.08.